Adjuvant Sunitinib for High-Risk Uveal Melanoma
Challenges of Type I Boston Keratoprosthesis in Children
Intravitreal Bevacizumab or Laser for ROP: 4-Year Outcomes
Serum VEGF Levels and Anti-VEGF Drugs: Results From IVAN
Phenotype of Uveitis in Children With Psoriatic Arthritis or Psoriasis
Scleral Lenses Reduce the Need for Corneal Transplant in Severe Keratoconus
Does the Presence of Trainees Have an Effect on the Duration of Patient Appointments?
Cataract Surgery Reduces Cause-Specific Mortality for Older Women
Trial of Dexamethasone Plus Ranibizumab for Persistent DME
Do Hyperreflective Dots on SD-OCT Predict Response to Macular Edema Treatment?
Prospective Trial of Corneal Reconstruction With Biomaterial-Free COMECs
Look out for the early signs and symptoms of this rare disease.
Explore TEPEZZA now.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2021 Horizon Therapeutics plc P-TEP-01315 08/21
Public & Patients
Museum of the Eye